Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Sledge

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Journal of the National Cancer Institute. Monographs|January 5, 2002
Is HER-2/neu a predictor of anthracycline utility? NoG W Sledge
Current Opinion in Oncology|October 1, 1990
Chemotherapy-induced nausea and vomitingG W Sledge
Indiana Medicine : the Journal of the Indiana State Medical Association|December 1, 1984
Breast cancer 1984: state of the artG W Sledge
Clinical Breast Cancer|March 20, 2002
The future of clinical research in breast cancer: challengesG W Sledge
Clinical Breast Cancer|March 20, 2002
All therapy is targeted therapy: the future of systemic therapyG W Sledge
Seminars in Oncology|October 1, 1996
Paclitaxel doublets in metastatic breast cancer: Eastern Cooperative Oncology Group and Hoosier Oncology Group StudiesG W Sledge
Seminars in Oncology|February 1, 1996
Implications of the new biology for therapy in breast cancerG W Sledge
Clinical Breast Cancer|March 20, 2002
A tale of two cities: Oxford and BethesdaG W Sledge
Clinical Breast Cancer|March 20, 2002
Hormones 'R' usG W Sledge
Clinical Breast Cancer|March 20, 2002
A seat at the tableG W Sledge
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Journal of the National Cancer Institute. Monographs|January 5, 2002
Is HER-2/neu a predictor of anthracycline utility? NoG W Sledge
Current Opinion in Oncology|October 1, 1990
Chemotherapy-induced nausea and vomitingG W Sledge
Indiana Medicine : the Journal of the Indiana State Medical Association|December 1, 1984
Breast cancer 1984: state of the artG W Sledge
Clinical Breast Cancer|March 20, 2002
The future of clinical research in breast cancer: challengesG W Sledge
Clinical Breast Cancer|March 20, 2002
All therapy is targeted therapy: the future of systemic therapyG W Sledge
Seminars in Oncology|October 1, 1996
Paclitaxel doublets in metastatic breast cancer: Eastern Cooperative Oncology Group and Hoosier Oncology Group StudiesG W Sledge
Seminars in Oncology|February 1, 1996
Implications of the new biology for therapy in breast cancerG W Sledge
Clinical Breast Cancer|March 20, 2002
A tale of two cities: Oxford and BethesdaG W Sledge
Clinical Breast Cancer|March 20, 2002
Hormones 'R' usG W Sledge
Clinical Breast Cancer|March 20, 2002
A seat at the tableG W Sledge
Pageof 12